News
-
Oncode Accelerator launched: patients at the centre of innovative cancer drug development 08 September 2023
Providing each cancer patient with the right treatment remains a challenge. Oncode Accelerator aims to change this by innovating the way we develop ca...
-
In conversation with the head of the rodent facility 06 September 2023
Before patients can take a pill, scientists often spend years in the lab developing and testing a candidate drug. That often includes experiments with...
-
Artificial intelligence as the co-pilot for drug discovery 23 May 2023
There are more molecules that could conceivably be candidate drugs than there are stars in the universe. How can we ever efficiently identify those mo...
-
Horizon Europe grant for research into personalised treatment for high blood pressure 18 April 2023
Professor Thomas Hankemeier and his international research team HYPERMARKER have received a 10m-euro grant from Horizon Europe and UK Research and Inn...
-
LUMC researchers: matching medication to DNA leads to 30% fewer side effects 03 February 2023
According to an international group of researchers led by Leiden University Medical Center (LUMC), patients experience 30% fewer serious side effects ...
-
Cells with stress: predicting drug-induced liver and kidney damage 26 January 2023
How can we prevent drug-induced liver and kidney damage? PhD candidates Marije Niemeijer and Lukas Wijaya investigated what happens in the cells durin...
-
From discovery to business: 'In the lab, we often don't realise that we are working to help an immense number of patients' 06 October 2022
'It gave our team a big boost to hear that our work was valuable,' says medical chemist Elmer Maurits about the moment they won the Venture Challenge....
-
Developing drugs with artificial intelligence 07 February 2022
Developing new drugs is a difficult process. With the aid of artificial intelligence, Pharmaceutical scientist Xuhan Liu has developed methods that ca...
-
Drugging the undruggable: NWO Open Competition grant for Alireza Mashaghi 04 January 2022
Finding structure in disordered proteins and developing drugs for undruggable diseases: it might sound like mission impossible, but pharmacologist Ali...
-
Adam Cohen receives Dr. Saal van Zwanenberg Honorary Prize 12 November 2021
Professor of Clinical Pharmacology Adam Cohen from Leiden University received the prestigious Dr. Saal van Zwanenberg Honorary Prize on 12 November. T...
-
Pharma company Janssen expands premises on Leiden Bio Science Park 03 November 2021
Pharma company Janssen has begun construction on a new office and lab building at the Leiden Bio Science Park. The first pile of the 13,500 square met...
-
Erik Danen part of NWO Perspectief grant for organ-on-chip 10 March 2021
A consortium of research groups, including that of LACDR professor Erik Danen, will use an NWO Perspective grant of nearly five million euros to build...
-
Medical Delta AI for Computational Life Sciences 16 February 2021
The fact that scientists are increasingly better able to access molecular cell and tissue data also brings with it a new challenge: how can scientists...
-
Laura Heitman appointed as Professor of Molecular Pharmacology 26 November 2020
As of 1 November, Laura Heitman has been appointed full Professor of Molecular Pharmacology at the Leiden Academic Centre for Drug Research (LACDR). H...
-
Leiden University and LUMC strengthen ties with Janssen pharmaceutical company 17 September 2020
Leiden University, the LUMC and Janssen have signed a partnership agreement stating that they will collaborate in different areas, including infectiou...